Navigating an Increasingly Complex Framework to Improve Patient Outcomes With ICI-Based Therapy

Review multidisciplinary best practices for safely and effectively incorporating immunotherapies into the management of diverse cancers with downloadable slides a Webcast expert commentaries and microlearning opportunities. Then get individualized recommendations adapted from NCCN Guidelines® for managing immune-related adverse events with a decision support tool.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Bristol Myers Squibb

Merck Sharp & Dohme Corp.